Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.53 |
| ▸ | HTR2B | P41595 | 2/20 | 0.53 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.53 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.53 |
| ▸ | ABL1 | P00519 | 3/20 | 0.46 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.46 |
| ▸ | BCR | P11274 | 3/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.45 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | CASP3 | P42574 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16528005 | 0.89 | LMNA (0.64) | LMNASLC6A2HTR2BTRPA1CHRM1 | |
| SCHEMBL7081272 | 0.84 | CA1 (0.50) | LMNASLC6A2HTR2BTRPA1CHRM1 | |
| SCHEMBL17878569 | 0.80 | ALOX5 (0.57) | LMNASLC6A2HTR2BTRPA1CHRM1 | |
| SCHEMBL383417 | 0.76 | LMNA (0.64) | LMNASLC6A2HTR2BTRPA1CHRM1 | |
| SCHEMBL29446964 | 0.76 | LMNA (0.64) | LMNASLC6A2HTR2BTRPA1CHRM1 | |
| SCHEMBL25494360 | 0.76 | RXRA (0.54) | LMNASLC6A2HTR2BTRPA1CHRM1 | |
| SCHEMBL19334617 | 0.76 | LMNA (0.48) | LMNASLC6A2HTR2BTRPA1CHRM1 | |
| SCHEMBL25092816 | 0.74 | TRPA1 (0.43) | LMNASLC6A2HTR2BTRPA1CHRM1 | |
| Resorcinol SCHEMBL23922720 | 0.73 | TYR (0.56) | LMNASLC6A2HTR2BTRPA1CHRM1 | |
| SCHEMBL25420702 | 0.73 | APP (0.74) | ABL1ABCB1BCRTP53APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030139479-A1 | Non-halogenated biphenyl triol compounds, antimicrobial compositions containing the same, and methods of using the same | WARNER-LAMBERT COMPANY | 2003-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030139479-A1 | Non-halogenated biphenyl triol compounds, antimicrobial compositions containing the same, and methods of using the same | AS3MT, PTPN1, NONO | LMNA 4693/4885SLC6A2 3535/4885HTR2B 3658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.